These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The physician and the pharmaceutical industry: both must keep the patient's interests at heart. Ravindran GD Issues Med Ethics; 1999; 7(1):21-2. PubMed ID: 16320467 [No Abstract] [Full Text] [Related]
3. Resident and fellow section. Conflicts of interest between physicians and the pharmaceutical industry: focus on headache medicine. Rubin EB; Bernat JL Headache; 2008; 48(10):1545-9. PubMed ID: 19076654 [No Abstract] [Full Text] [Related]
4. Proposed guidelines for housestaff interaction with pharmaceutical companies. Forrest DM; Ruedy J Ann R Coll Physicians Surg Can; 1993 Oct; 26(5):291-3. PubMed ID: 15362243 [TBL] [Abstract][Full Text] [Related]
5. Recognising expertise would help to attract independent experts. Prescrire Int; 2010 Aug; 19(108):187. PubMed ID: 20939462 [No Abstract] [Full Text] [Related]
6. The ethics of pharmaceutical industry gift-giving: the role of a professional association. Morin K; Morse LJ Am J Bioeth; 2003; 3(3):54-5. PubMed ID: 14594494 [No Abstract] [Full Text] [Related]
7. Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings. Lammers A; Edmiston J; Kaestner V; Prasad V Mayo Clin Proc; 2017 Jul; 92(7):1164-1166. PubMed ID: 28688469 [No Abstract] [Full Text] [Related]
8. Managing physician financial conflicts of interest in clinical trials conducted in the private practice setting. Williams KM Food Drug Law J; 2004; 59(1):45-77. PubMed ID: 15190925 [No Abstract] [Full Text] [Related]
9. Ethical issues in the representation of individuals in the commitment process. Perlin ML; Sadoff RL Law Contemp Probl; 1982; 45(3):161-92. PubMed ID: 11645494 [No Abstract] [Full Text] [Related]
10. The law, the psychiatrist, and the patient. Bazelon DL Man Med; 1980; 5(2):77-86. PubMed ID: 12083125 [No Abstract] [Full Text] [Related]
11. The treating physician as expert witness: ethical and pragmatic considerations. Rich BA Pain Med; 2006; 7(5):460-3. PubMed ID: 17014608 [TBL] [Abstract][Full Text] [Related]
16. Pain Medicine Ethics Forum: Key Opinion Leaders with Industry Conflicts of Interest Should Be Able to Hold Leadership Positions in Professional Medical Associations. Wallace MS Pain Med; 2016 Feb; 17(2):218. PubMed ID: 26814302 [No Abstract] [Full Text] [Related]
17. Advocate for all patients: the physician in health-policy formulation. Senn JS Humane Med; 1988 May; 4(1):24-7. PubMed ID: 11659024 [No Abstract] [Full Text] [Related]
18. Code of ethics: CMA policy summary. Canadian Medical Association CMAJ; 1987 Oct; 137(8):760A-D. PubMed ID: 11658965 [No Abstract] [Full Text] [Related]
19. American academy of pain medicine ethics council statement on conflicts of interest: interaction between physicians and industry in pain medicine. Dubois MY; Pain Med; 2010 Feb; 11(2):257-62. PubMed ID: 19930112 [TBL] [Abstract][Full Text] [Related]
20. Let the sunshine in--making industry payments to New Zealand doctors transparent. Farquhar C; Stokes T; Grey A; Jeffery M; Griffin P N Z Med J; 2015 Mar; 128(1411):6-12. PubMed ID: 25820497 [No Abstract] [Full Text] [Related] [Next] [New Search]